1. Home
  2. FATN vs RAPT Comparison

FATN vs RAPT Comparison

Compare FATN & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATN
  • RAPT
  • Stock Information
  • Founded
  • FATN 1989
  • RAPT 2015
  • Country
  • FATN United States
  • RAPT United States
  • Employees
  • FATN N/A
  • RAPT N/A
  • Industry
  • FATN
  • RAPT Biotechnology: Pharmaceutical Preparations
  • Sector
  • FATN
  • RAPT Health Care
  • Exchange
  • FATN NYSE
  • RAPT Nasdaq
  • Market Cap
  • FATN 116.8M
  • RAPT 117.5M
  • IPO Year
  • FATN 2025
  • RAPT 2019
  • Fundamental
  • Price
  • FATN $8.63
  • RAPT $7.35
  • Analyst Decision
  • FATN
  • RAPT Buy
  • Analyst Count
  • FATN 0
  • RAPT 5
  • Target Price
  • FATN N/A
  • RAPT $42.00
  • AVG Volume (30 Days)
  • FATN 57.0K
  • RAPT 118.3K
  • Earning Date
  • FATN 01-01-0001
  • RAPT 08-07-2025
  • Dividend Yield
  • FATN N/A
  • RAPT N/A
  • EPS Growth
  • FATN 56.77
  • RAPT N/A
  • EPS
  • FATN 0.37
  • RAPT N/A
  • Revenue
  • FATN $17,876,645.00
  • RAPT N/A
  • Revenue This Year
  • FATN N/A
  • RAPT N/A
  • Revenue Next Year
  • FATN N/A
  • RAPT N/A
  • P/E Ratio
  • FATN $22.68
  • RAPT N/A
  • Revenue Growth
  • FATN 13.17
  • RAPT N/A
  • 52 Week Low
  • FATN $5.60
  • RAPT $5.67
  • 52 Week High
  • FATN $23.27
  • RAPT $30.60
  • Technical
  • Relative Strength Index (RSI)
  • FATN N/A
  • RAPT 43.57
  • Support Level
  • FATN N/A
  • RAPT $6.88
  • Resistance Level
  • FATN N/A
  • RAPT $8.91
  • Average True Range (ATR)
  • FATN 0.00
  • RAPT 0.70
  • MACD
  • FATN 0.00
  • RAPT -0.16
  • Stochastic Oscillator
  • FATN 0.00
  • RAPT 11.36

About FATN FATPIPE INC

Fatpipe Inc is a pioneer in enterprise-class, application-aware, secure SD-WAN solutions for organizations, including enterprises, communication service providers, security service providers, government organizations, and other middle-market companies. It is engaged in delivering principal enterprise-class networking software technology. The company is dedicated to continually improving the way organizations connect, ensuring their networks are secure, reliable, and supporting their continued success. Its commitment lies in empowering its customers with a seamless and dependable connectivity infrastructure that safeguards their critical data and fosters business continuity. Further, the company's goal is to ensure its customers have unparalleled insights into their network operations.

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Share on Social Networks: